165 related articles for article (PubMed ID: 537)
21. Partial purification of adenosine 3',5'-cyclic monophosphate phosphodiesterases from rat pancreas in the presence of excess protease inhibitors.
Terai M; Furihata C; Matsushima T; Sugimura T
Arch Biochem Biophys; 1976 Oct; 176(2):621-9. PubMed ID: 185966
[No Abstract] [Full Text] [Related]
22. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from the cytosol of human platelets.
Grant PG; Mannarino AF; Colman RW
Thromb Res; 1990 Jul; 59(1):105-19. PubMed ID: 2169075
[TBL] [Abstract][Full Text] [Related]
23. Cyclic 3',5'-nucleotide phosphodiesterase in rat skin. II. Biochemical characterization.
King LE; Solomon SS; Hasimoto K
J Invest Dermatol; 1975 Jun; 64(6):390-6. PubMed ID: 237964
[TBL] [Abstract][Full Text] [Related]
24. Cyclic nucleotide phosphodiesterases in neoplastic and nonneoplastic human mammary tissues.
Singer AL; Sherwin RP; Dunn AS; Appleman MM
Cancer Res; 1976 Jan; 36(1):60-6. PubMed ID: 174814
[TBL] [Abstract][Full Text] [Related]
25. Partial purification of adenosine 3':5'-clclic monophosphate phosphodiesterase from Phaseolus vulgaris l.: associated activator and inhibitors.
Brown EG; Al-Najafi T; Newton RP
Biochem Soc Trans; 1975; 3(3):393-5. PubMed ID: 165999
[No Abstract] [Full Text] [Related]
26. Regulation of cyclic nucleotide phosphodiesterases in cultured hepatoma cells by dexamethasone and N6,O2'-dibutyryl adenosine 3':k'-monophosphate.
Ross PS; Manganiello VC; Vaughan M
J Biol Chem; 1977 Feb; 252(4):1448-52. PubMed ID: 190234
[TBL] [Abstract][Full Text] [Related]
27. Adrenal medullary cyclic nucleotide phosphodiesterase. Subcellular distribution, partial purification and regulation of enzyme activity.
Egrie JC; Siegel FL
Biochim Biophys Acta; 1977 Aug; 483(2):348-66. PubMed ID: 196651
[No Abstract] [Full Text] [Related]
28. Cyclic nucleotide hydrolysis in the thyroid gland. General properties and key role in the interrelations between concentrations of adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate.
Erneux C; Van Sande J; Dumont JE; Boeynaems JM
Eur J Biochem; 1977 Jan; 72(1):137-47. PubMed ID: 12974
[TBL] [Abstract][Full Text] [Related]
29. Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions.
LeBon TR; Kasuya J; Paxton RJ; Belfrage P; Hockman S; Manganiello VC; Fujita Yamaguchi Y
Endocrinology; 1992 Jun; 130(6):3265-74. PubMed ID: 1317779
[TBL] [Abstract][Full Text] [Related]
30. Purification and characterization of high-affinity cyclic adenosine 5'-monophosphate phosphodiesterases from human acute myelogenous leukemic cells.
Onali P; Strada SJ; Chang L; Epstein PM; Hersh EM; Thompson WJ
Cancer Res; 1985 Mar; 45(3):1384-91. PubMed ID: 2982489
[TBL] [Abstract][Full Text] [Related]
31. Cyclic 3',5'-AMP phosphodiesterase of rabbit aorta.
Hidaka H; Asano T; Shimamoto T
Biochim Biophys Acta; 1975 Jan; 377(1):103-16. PubMed ID: 164219
[TBL] [Abstract][Full Text] [Related]
32. Purification and characterization of human lung calmodulin-independent cyclic AMP phosphodiesterase.
Moore JB; Schroedter DE
Arch Biochem Biophys; 1982 Jan; 213(1):276-87. PubMed ID: 6277253
[No Abstract] [Full Text] [Related]
33. Cyclic nucleotide phosphodiesterases in the cricket, Acheta domesticus.
Fallon AM; Wyatt GR
Biochim Biophys Acta; 1977 Feb; 480(2):428-41. PubMed ID: 189817
[TBL] [Abstract][Full Text] [Related]
34. Characterization of cyclic nucleotide phosphodiesterases with multiple separation techniques.
Van Inwegen RG; Pledger WJ; Strada SJ; Thompson WJ
Arch Biochem Biophys; 1976 Aug; 175(2):700-9. PubMed ID: 183123
[No Abstract] [Full Text] [Related]
35. Solubilization and characterization of hormone- responsive phosphodiesterase activity of rat fat cells.
Lovell-Smith CJ; Manganiello VC; Vaughan M
Biochim Biophys Acta; 1977 Apr; 497(2):447-58. PubMed ID: 192314
[TBL] [Abstract][Full Text] [Related]
36. Cyclic adenosine 3':5'-monophosphate phosphodiesterase. Distinct forms in human lymphocytes and monocytes.
Thompson WJ; Ross CP; Pledger WJ; Strada SJ; Banner RL; Hersh EM
J Biol Chem; 1976 Aug; 251(16):4922-9. PubMed ID: 182685
[TBL] [Abstract][Full Text] [Related]
37. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
Eckly AE; Lugnier C
Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of cyclic nucleotide phosphodiesterases from rat brain by activator protein, proteolytic enzymes and a vitamin E derivative.
Sakai T; Yamanaka H; Tanaka R; Makino H; Kasai H
Biochim Biophys Acta; 1977 Jul; 483(1):121-34. PubMed ID: 195621
[No Abstract] [Full Text] [Related]
39. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
Kireeva NN; Bobruskin ID; Severin SE
Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
[TBL] [Abstract][Full Text] [Related]
40. Properties of 3',5'-cyclic-AMP phosphodiesterase from Paragonimus africanus metacercariae.
Walter RD
Tropenmed Parasitol; 1976 Sep; 27(3):337-42. PubMed ID: 10655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
